At the conclusion of this activity, learners should be able to: 1. Apply for a waiver to prescribe buprenorphine to their patients with opioid use disorders 2. Identify and assess patients who are appropriate for treatment with medications 3. Have specific knowledge concerning the use of medications to manage patients with addiction involving opioid use 4. Discuss the psychiatric and medical co-morbidities associated with opioid addiction Apply • Fill out the Waiver Notification Form on SAMHSA’s website. • Submit copies of your training certificate(s) to SAMHSA by email: infobuprenorphine@samhsa.hhs.govor fax: 301.576.5237. SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number. Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number. If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: infobuprenorphine@samhsa.hhs.gov or call 866.287.2728. Welcome to The ASAM Treatment of Opioid Use Disorder Course. This course provides the 8 hours of education needed to receive a waiver to prescribe buprenorphine in an office-based setting. More information on waiver requirements can be found on the SAMHSA website. To begin the online portion of the course, please log in to your right and locate the box that says Module 1. If you do not know your password, or you have forgotten it, select "Forgot Password" and you will be emailed a link to reset your password. This 8-hour online course combines modules from our blended course and Video On-Demand captured on October 5, 2016 in Washington, DC. All online modules and quizzes must be completed before moving on to Video On-Demand. Detailed instructions for completing the online portion of the course can be found under the tab titled "Course Instructions." After completing the online modules, Videos On-Demand, corresponding quizzes, and applicable evaluations, return here to claim CME for the course. If you have any questions, please contact education@ASAM.org. Note: Resident & Fellow ASAM Members (in training) receive complimentary access to the 8-hour online ASAM Treatment of Opioid Use Disorder Course. Click here to become a member. Please note membership approval requires up to two business days. ________________________________________ Overview of Legislation Physicians The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office-based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses